Adopting Low-Risk Dietary And Lifestyle Factors Related To Lower Incidence Of High Blood Pressure

Posted by poster | Uncategorized | Sunday 9 August 2009 2:35 am

Adherence to modifiable lifestyle and dietary factors including maintaining normal weight, daily vigorous exercise, eating a diet high in fruits, vegetables, low-fat dairy products and low in sodium and taking a folic acid supplement was associated with a significantly lower incidence of self-reported hypertension among women, according to a study in the July 22/29 issue of JAMA.
Hypertension (high blood pressure) contributes to more (more…)

FDA Approves Tekturna HCT(R) As Initial Treatment In Patients Unlikely To Achieve Their Blood Pressure Goals With A Single Agent

Posted by poster | Uncategorized | Friday 7 August 2009 1:35 am

The US Food and Drug Administration (FDA) has approved Tekturna HCT((R)) (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tekturna HCT is a single-pill combination of Tekturna((R)) (aliskiren), the first and only approved direct renin inhibitor, and the diuretic hydrochlorothiazide (HCTZ), one (more…)

Hampton Court Allergy Screening A Success, UK

Posted by poster | Uncategorized | Wednesday 5 August 2009 1:35 am

The National Pharmacy Association and Allergy UK provided free allergy screening to the public at Hampton Court Palace Flower Show from 7-12 July. Over 7,000 members of the public picked up information on community pharmacy allergy screening or asked for advice and 75 allergy screenings were carried out.
Jules Payne, Deputy Chief Executive, Allergy UK said: "Allergy UK has done a lot of shows over the years (more…)

Labopharm Receives Complete Response Letter From The U.S. FDA For Novel Antidepressant

Posted by poster | Uncategorized | Monday 3 August 2009 12:35 am

Buy generic soma Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for the new drug application (NDA) submission of its novel formulation of the antidepressant trazodone.
The letter indicates Labopharm’s application cannot be approved in its present (more…)

Mental Health Issues Among Veterans Increase Dramatically

Posted by poster | Uncategorized | Saturday 1 August 2009 1:35 am

A new study finds more veterans being diagnosed with mental health issues. The study was posted Thursday on the web site of The American Journal of Public Health.
The New York Times reports: "A new study has found that more than one-third of Iraq and Afghanistan war veterans who enrolled in the veterans health system after 2001 received a diagnosis of a mental health problem, most often post-traumatic stress disorder or depression. The (more…)

« Previous PageNext Page »